INVESTOR RELATIONS

News

Date Title and Summary Additional Formats
Toggle Summary NantKwest to Present at Jefferies 2018 Global Healthcare Conference
CULVER CITY, Calif. --(BUSINESS WIRE)--Jun. 5, 2018-- NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell based therapeutics company, today announced that Dr. Patrick Soon-Shiong , Chairman & CEO of NantKwest , will be presenting and conducting one-on-one meetings at the upcoming
View HTML
Toggle Summary NantKwest to Present at the 37th Annual Canaccord Genuity Growth Conference
CULVER CITY, Calif. --(BUSINESS WIRE)--Aug. 7, 2017-- NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell-based therapeutics company, today announced that the company will be presenting at the 37 th Annual Canaccord Genuity Growth Conference taking place August 9-10, 2017 in
View HTML
Toggle Summary NantKwest to Present at the Jefferies Healthcare Conference on June 7, 2017
CULVER CITY, Calif. --(BUSINESS WIRE)--Jun. 2, 2017-- NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell based therapeutics company, today announced that the company will be presenting at the Jefferies 2017 Global Healthcare Conference on Wednesday, June 7 th , in New York City at
View HTML
Toggle Summary NantKwest to Present at the Piper Jaffray 28th Annual Health Care Conference
CULVER CITY, Calif. --(BUSINESS WIRE)--Nov. 28, 2016-- NantKwest Inc. (Nasdaq:NK) today announced that Company management will present at the Piper Jaffray 28 th Annual Health Care Conference in New York, NY at 4:00 pm Eastern Time (ET) on Tuesday, November 29, 2016 .
View HTML
Toggle Summary NantKwest to Present at Upcoming Investment and Healthcare Conferences
CULVER CITY, Calif. --(BUSINESS WIRE)--Mar. 13, 2018-- NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell-based therapeutics company, today announced that the company will be presenting and conducting one-on-one meetings at a number of investment and healthcare conferences in the
View HTML
Toggle Summary NantKwest to Present at Upcoming Investment and Healthcare Conferences
CULVER CITY, Calif. --(BUSINESS WIRE)--Mar. 13, 2018-- NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell-based therapeutics company, today announced that the company will be presenting and conducting one-on-one meetings at a number of investment and healthcare conferences in the
View HTML
Toggle Summary NantKwest to Present at Upcoming Investment Conferences
CULVER CITY, CALIFORNIA-(BUSINESS WIRE), September 5, 2017 NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell based therapeutics company, today announced that the company will be presenting at three investment conference in September.
View HTML
Toggle Summary NantKwest to Present at Upcoming Investor Conferences
CULVER CITY, Calif. --(BUSINESS WIRE)--Mar. 6, 2017-- NantKwest (Nasdaq:NK) today announced that members of the company’s management team will be presenting at the following upcoming investor conferences: Cowen & Company’s 37th Annual Healthcare Conference on Wednesday, March 8th , at 9:20am ET
View HTML
Toggle Summary NantKwest to Present at Upcoming Science & Medicine Conferences
CULVER CITY, Calif. --(BUSINESS WIRE)--Apr. 23, 2018-- NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell based therapeutics company, today announced that the company will be presenting at two science and medicine conferences in the months of April and May 2018 .
View HTML
Toggle Summary NantKwest to Present Data at the 58th Annual Meeting of the American Society of Hematology
Presentation of Combination Therapy with a CS1.taNK and Daratumumab in Multiple Myeloma Presentation of Activated Natural Killer Cell Therapy (aNK) in Acute Myeloid Leukemia Presentation of Preclinical Data of a CD19.taNK Targeting Non-Hodgkin Lymphoma CULVER CITY, Calif. --(BUSINESS WIRE)--Nov.
View HTML